JP2005513014A5 - - Google Patents

Download PDF

Info

Publication number
JP2005513014A5
JP2005513014A5 JP2003543603A JP2003543603A JP2005513014A5 JP 2005513014 A5 JP2005513014 A5 JP 2005513014A5 JP 2003543603 A JP2003543603 A JP 2003543603A JP 2003543603 A JP2003543603 A JP 2003543603A JP 2005513014 A5 JP2005513014 A5 JP 2005513014A5
Authority
JP
Japan
Prior art keywords
dosage unit
analog
range
present
suitable excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003543603A
Other languages
English (en)
Japanese (ja)
Other versions
JP4852229B2 (ja
JP2005513014A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2002/011862 external-priority patent/WO2003041716A1/en
Publication of JP2005513014A publication Critical patent/JP2005513014A/ja
Publication of JP2005513014A5 publication Critical patent/JP2005513014A5/ja
Application granted granted Critical
Publication of JP4852229B2 publication Critical patent/JP4852229B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003543603A 2001-11-14 2002-11-14 便秘の処置用のプロスタグランジンアナログを含む用量単位 Expired - Lifetime JP4852229B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33131601P 2001-11-14 2001-11-14
US60/331,316 2001-11-14
PCT/JP2002/011862 WO2003041716A1 (en) 2001-11-14 2002-11-14 Dosage unit comprising a prostaglandin analog for treating constipation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011117231A Division JP2011201905A (ja) 2001-11-14 2011-05-25 便秘の処置用のプロスタグランジンアナログを含む用量単位

Publications (3)

Publication Number Publication Date
JP2005513014A JP2005513014A (ja) 2005-05-12
JP2005513014A5 true JP2005513014A5 (OSRAM) 2006-01-12
JP4852229B2 JP4852229B2 (ja) 2012-01-11

Family

ID=23293447

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003543603A Expired - Lifetime JP4852229B2 (ja) 2001-11-14 2002-11-14 便秘の処置用のプロスタグランジンアナログを含む用量単位
JP2011117231A Pending JP2011201905A (ja) 2001-11-14 2011-05-25 便秘の処置用のプロスタグランジンアナログを含む用量単位

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011117231A Pending JP2011201905A (ja) 2001-11-14 2011-05-25 便秘の処置用のプロスタグランジンアナログを含む用量単位

Country Status (14)

Country Link
US (3) US8097653B2 (OSRAM)
EP (2) EP1443938B1 (OSRAM)
JP (2) JP4852229B2 (OSRAM)
AR (3) AR037524A1 (OSRAM)
AT (1) ATE522218T1 (OSRAM)
BR (1) BR0214075A (OSRAM)
CA (1) CA2464420C (OSRAM)
CY (1) CY1115856T1 (OSRAM)
DK (2) DK2298314T3 (OSRAM)
ES (2) ES2524369T3 (OSRAM)
LU (1) LU92826I2 (OSRAM)
PT (2) PT2298314E (OSRAM)
TW (1) TWI331920B (OSRAM)
WO (1) WO2003041716A1 (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US8114911B2 (en) * 2002-10-23 2012-02-14 Sucampo Ag Prostaglandin compounds for the treatment of obesity
ES2591252T3 (es) * 2002-12-27 2016-11-25 Sucampo Ag Derivados de prostaglandinas para tratar el síndrome de colon irritable y/o la dispepsia funcional
JP5294559B2 (ja) * 2003-07-03 2013-09-18 スキャンポ・アーゲー クロライドチャンネルオープナーとしてプロスタグランジンアナログを含む腸溶性組成物
TWI387454B (zh) * 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
CN101171010B (zh) * 2005-03-07 2014-09-17 芝加哥大学 阿片样物质拮抗剂用于减少内皮细胞增殖和迁移的用途
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
KR20140069182A (ko) * 2005-04-12 2014-06-09 수캄포 아게 위장 장애 치료를 위한 프로스타글란딘 화합물과 양성자 펌프 억제제의 병용
PT1978944E (pt) * 2006-01-24 2012-11-26 Sucampo Ag Formulação em cápsula de gelatina mole
KR20140147142A (ko) * 2006-01-24 2014-12-29 가부시키가이샤 아루떼꾸 우에노 바이-사이클릭 화합물을 함유하는 약학적 조성물 및 바이-사이클릭 화합물의 안정화 방법
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
US20090012165A1 (en) * 2007-07-03 2009-01-08 Sucampo Ag Pharmaceutical combination of nsaid and prostaglandin compound
KR20120092592A (ko) * 2009-09-18 2012-08-21 아돌로 코포레이션 위장관 질환을 위한 오피오이드 수용체 길항제의 용도
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5350141A (en) 1976-10-18 1978-05-08 Ono Pharmaceut Co Ltd Stabilization of prostaglandin and prostaglandin analogues
GB1581886A (en) 1977-05-26 1980-12-31 May & Baker Ltd Prostanol derivatives
JPH0681728B2 (ja) 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
ES2051862T3 (es) * 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030346C (en) * 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
CA2030344C (en) 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2041417C (en) * 1990-05-01 2002-05-21 Ryuji Ueno Treatment of pancreatic disease with 15-keto-prostaglandin compounds
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
JP2938579B2 (ja) 1990-12-15 1999-08-23 株式会社上野製薬応用研究所 消化管壁保護剤
DK0503887T3 (da) * 1991-03-14 1996-09-16 R Tech Ueno Ltd Fremme af sårheling med 15-ketoprostaglandinforbindelser
ATE169015T1 (de) * 1992-02-04 1998-08-15 Eisai Co Ltd Aminobenzoesäure derivate
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
JP3183615B2 (ja) * 1994-06-03 2001-07-09 株式会社アールテック・ウエノ 肝・胆道系疾患処置剤
WO1997047595A1 (en) * 1996-06-10 1997-12-18 R-Tech Ueno, Ltd. Endothelin antagonist
DE19717005A1 (de) * 1997-04-23 1998-10-29 Kennametal Inc Spannfutter für Rundlaufwerkzeuge
PT978284E (pt) * 1997-11-28 2008-10-07 Sucampo Ag Utilização de compostos 15-ceto-prostaglandina-e como antagonistas da endotelina
US6492417B1 (en) 1997-12-22 2002-12-10 Alcon Manufacturing, Ltd. 11-deoxy-16-fluoro-PGF2α analogs as FP receptor antagonists
ATE402925T2 (de) * 1999-10-15 2008-08-15 Sucampo Ag Neue zusammensetzung enthaltend eine bicyclische verbindung und ein glycerid
ATE433754T1 (de) 2000-04-06 2009-07-15 Sucampo Ag Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
ATE387204T1 (de) 2001-05-18 2008-03-15 Sucampo Ag Zusammensetzung mit induzierendem kathartischen effekt
CA2458471C (en) * 2001-08-31 2012-07-31 Sucampo Ag Prostaglandin analogs as chloride channel opener
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
ES2591252T3 (es) * 2002-12-27 2016-11-25 Sucampo Ag Derivados de prostaglandinas para tratar el síndrome de colon irritable y/o la dispepsia funcional

Similar Documents

Publication Publication Date Title
JP2005513014A5 (OSRAM)
JP2003531118A5 (OSRAM)
JP2005533860A5 (OSRAM)
JP2006182786A5 (OSRAM)
CA2445145A1 (en) Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
IL160028A (en) Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy
JP2004508410A5 (OSRAM)
EP1797878A3 (en) Benzothiazole derivatives
JP2005508337A5 (OSRAM)
JP2003503449A5 (OSRAM)
JP2007176958A (ja) セチリジン及びプソイドエフェドリンを含む錠剤
CA2464420A1 (en) Dosage unit comprising a prostaglandin analog for treating constipation
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
MD523G2 (ro) Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
JP2004532828A5 (OSRAM)
JP2002509164A5 (OSRAM)
JP2001520994A5 (OSRAM)
CN1172669C (zh) 沙利度坦在制造治疗或预防主要抑郁性病症的药物中的应用
CA2389032A1 (en) Preventive or therapeutic agents for inflammatory diseases of intestine
JPH1036365A5 (OSRAM)
JP2005524666A5 (OSRAM)
JPH02233613A (ja) ピペリジノアルカノール誘導体類用の液体製剤組成物
JP2004514709A5 (OSRAM)
JP2005515155A5 (OSRAM)
JP2004512376A5 (OSRAM)